poxvirus
identifi
skin
lesion
domest
pet
wild
bird
assign
larg
default
avipoxviru
genu
within
subfamili
chordopoxvirina
famili
poxvirida
avipoxvirus
identifi
caus
agent
diseas
least
speci
order
bird
vaccin
base
upon
attenu
avipoxviru
strain
provid
good
diseas
control
product
poultri
although
larg
intens
product
system
suggest
real
risk
emerg
strain
current
vaccin
might
ineffect
sequenc
analysi
whole
genom
reveal
overal
genom
structur
function
resembl
chordopoxvirina
howev
avipoxviru
genom
exhibit
largescal
genom
rearrang
extens
gene
famili
novel
host
rang
gene
comparison
chordopoxvirina
phylogenet
analysi
place
avipoxvirus
extern
chorodopoxvirina
extent
futur
might
appropri
consid
avipoxvirus
separ
subfamili
within
poxvirida
uniqu
relationship
exist
fowlpox
viru
fwpv
reticuloendothelosi
virus
fwpv
strain
carri
remnant
long
termin
repeat
field
strain
carri
near
fulllength
proviru
integr
locat
fwpv
genom
develop
techniqu
construct
poxvirus
express
foreign
vaccin
antigen
avipoxvirus
gone
neglect
obscur
import
vaccin
vector
past
year
semin
observ
util
deliveri
vaccin
antigen
nonavian
speci
driven
much
interest
group
virus
veterinari
area
sever
recombin
avipoxvirus
commerci
licens
vaccin
success
express
glycoprotein
antigen
envelop
virus
eg
avian
influenza
newcastl
diseas
west
nile
virus
sever
recombin
undergon
extens
human
clinic
trial
experiment
vaccin
hivaid
malaria
treatment
regimen
cancer
patient
safeti
profil
avipoxviru
recombin
use
veterinari
human
vaccin
therapeut
well
establish
poxvirus
identifi
skin
lesion
domest
pet
wild
bird
assign
larg
default
avipoxviru
genu
within
subfamili
chordopoxvirina
famili
poxvirida
diseas
characteris
prolif
lesion
skin
rang
small
nodul
tumour
wartlik
mass
rare
prolif
diphther
membran
mucou
membran
respiratori
tract
mouth
oesophagu
avipoxvirus
usual
assign
speci
name
basi
bird
speci
viru
isol
least
describ
light
electron
microscopi
lesion
understand
relationship
avipoxviru
speci
type
speci
fowlpox
viru
fwpv
rudimentari
sinc
detail
genom
inform
current
avail
two
fwpv
isol
one
canarypox
viru
cnpv
isol
detail
studi
fwpv
cnpv
driven
larg
use
vaccin
vector
poultri
human
vaccin
avipoxvirus
identifi
caus
agent
diseas
wide
rang
avian
speci
review
avail
literatur
reveal
natur
infect
describ
least
speci
order
bird
instanc
infect
consider
concern
threat
endang
speci
speci
captiv
breed
recoveri
program
diseas
caus
fwpv
domest
poultri
one
major
diseas
concern
commerci
poultri
product
caus
signific
problem
time
time
condit
favour
transmiss
predominantli
mechan
transmiss
mosquito
attenu
strain
fwpv
avipoxvirus
success
wide
use
vaccin
suscept
speci
diseas
control
detail
understand
molecular
virolog
relationship
avipoxvirus
larg
restrict
fwpv
cnpv
fullgenom
sequenc
avail
studi
reveal
characterist
poxviru
morpholog
larg
doublestrand
dna
genom
kbp
fwpv
kbp
cnpv
cytoplasm
replic
gene
express
regulatori
element
common
chordopoxvirina
genom
encod
excess
put
gene
genom
avipoxvirus
exhibit
largescal
genom
rearrang
extens
gene
famili
novel
host
rang
gene
comparison
member
chordopoxvirina
uniqu
relationship
exist
fwpv
avian
retroviru
reticuloendotheliosi
viru
rev
fwpv
vaccin
strain
carri
remnant
long
termin
repeat
ltr
field
strain
carri
near
fulllength
proviru
integr
locat
proviru
give
rise
rev
infect
fwpv
infect
suscept
poultri
rev
sequenc
detect
avipoxvirus
perhap
greatest
interest
avipoxvirus
use
vaccin
vector
firstli
deliv
vaccin
antigen
poultri
secondli
vaccin
vector
nonavian
speci
mani
techniqu
develop
construct
orthopoxviru
recombin
readili
adapt
construct
avipoxviru
recombin
appropri
chang
cell
substrat
select
protocol
approach
billion
dose
recombin
fwpv
rfwpv
avian
influenza
vaccin
use
control
avian
influenza
mexico
observ
fwpv
cnpv
infect
wide
rang
mammalian
cell
without
product
replic
gene
express
occur
level
suffici
induc
antibodi
cellular
protect
immun
respons
recombin
antigen
driver
substanti
interest
use
avipoxvirus
vaccin
vector
nonavian
speci
includ
man
util
avipoxviru
vaccin
vector
extend
primeboost
vaccin
regimen
deliveri
cancer
immunestimulatorymodulatori
molecul
treatment
regimen
number
avipoxviru
recombin
undergon
extens
preclin
clinic
trial
includ
vaccin
candid
control
hivaid
malaria
safeti
profil
recombin
well
establish
avipoxvirus
classifi
famili
poxvirida
subfamili
chordopoxvirina
genu
avipoxviru
type
speci
well
known
characteris
fwpv
mani
differ
isol
fwpv
describ
includ
wide
rang
commerci
vaccin
avail
global
ten
offici
speci
accept
sever
tent
speci
genu
tab
speci
demarc
poorli
defin
criteria
includ
diseas
characterist
origin
host
growth
characterist
chorioallanto
membran
embryon
egg
avian
cell
cultur
crossprotect
chicken
classic
fwpv
restrict
endonucleas
analysi
genom
dna
crosshybridis
given
size
complex
avipoxvirus
genom
virion
level
understand
extent
natur
relationship
offici
tent
speci
best
rudimentari
nucleotid
sequenc
determin
select
conserv
gene
might
provid
mean
presumpt
classif
attempt
use
gene
howev
relationship
defin
basi
fail
take
account
variat
gene
content
aris
gene
loss
gain
evolut
avipoxvirus
may
well
largest
divers
genu
chordopoxvirina
although
origin
bird
controversi
probabl
around
form
least
million
year
avipoxvirus
almost
certainli
coevolv
host
process
acquir
gene
host
assist
viru
counter
host
cellular
immun
respons
avipoxvirus
accept
speci
tend
success
cultiv
laboratori
fwp
product
chicken
turkey
tend
slowspread
characterist
skin
lesion
rang
small
nodul
tumour
wartlik
mass
occur
predominantli
unfeath
skin
area
eg
head
leg
mortal
low
howev
substanti
transient
drop
egg
product
occur
lay
bird
young
bird
growth
rate
significantli
affect
role
simultan
rev
infect
aris
proviru
integr
fwpv
genom
might
play
express
fwp
unknown
howev
potenti
effect
rev
infect
discount
sinc
rev
infect
known
lead
immunosuppress
sever
diphtherit
form
fwp
prolif
lesion
nasal
laryng
tracheal
region
result
respiratori
distress
higher
mortal
control
diseas
caus
avipoxvirus
best
achiev
prevent
transmiss
vaccin
suitabl
specif
treatment
avail
infect
establish
transmiss
bite
insect
particularli
mosquito
link
season
geograph
incid
diseas
appropri
screen
insect
control
program
commerci
poultri
product
reduc
impact
diseas
infect
via
cutan
injuri
inhal
reduc
control
crowd
decontamin
premis
follow
outbreak
fwpv
surviv
dri
scab
extend
period
week
month
attent
sanit
hous
feed
water
essenti
effect
diseas
prevent
fwp
distribut
worldwid
domest
poultri
incid
variabl
differ
geograph
region
relat
manag
hygien
practic
mosquito
control
use
prophylact
vaccin
prophylact
vaccin
control
fwp
commerci
poultri
practic
consider
period
time
earli
histori
vaccin
fwp
pigeonpox
pgp
turkeypox
tkp
cnp
well
document
beaudett
refer
provid
fascin
insight
earli
attempt
vaccin
avipox
understand
relationship
amongst
avipoxvirus
sinc
late
earli
modern
commerci
vaccin
avail
region
world
control
fwp
vaccin
eg
tkp
quailpox
qup
cnp
pgp
avail
specif
region
viru
strain
use
vaccin
deriv
empir
passag
field
isol
embryon
egg
chicken
embryoderiv
cell
cultur
select
basi
immunogen
protect
challeng
attenu
reduc
pathogen
comparison
origin
field
strain
basi
freedom
avian
pathogen
vaccin
found
widespread
use
control
avipox
diseas
origin
histori
mani
name
vaccin
strain
obscur
commerci
consider
loss
inform
passag
time
avipox
vaccin
effect
appli
wing
web
inocul
use
singl
two
prong
needl
inocul
make
vaccin
expens
administ
commerci
poultri
bird
need
handl
vaccin
take
assess
inspect
inocul
site
develop
characterist
pox
lesion
day
vaccin
administr
rout
eg
drink
water
spray
far
less
effect
induct
protect
immun
much
higher
viru
concentr
need
achiev
accept
level
protect
ovo
vaccin
close
hatch
date
highli
attenu
rfwpv
strain
may
viabl
altern
individu
chick
vaccin
revaccin
may
necessari
sustain
protect
chicken
use
egg
product
subject
heavi
challeng
high
mosquito
popul
fwpv
vaccin
strain
rang
highli
attenu
suitabl
vaccin
chick
other
residu
pathogen
recommend
first
use
week
age
revaccin
immedi
prior
commenc
lay
fwpv
vaccin
provid
littl
effect
protect
tkpv
qupv
cnpv
consequ
essenti
use
appropri
vaccin
diseas
control
speci
poor
crossprotect
probabl
relat
antigen
differ
exist
virus
vaccin
sometim
practic
circumst
small
proport
bird
show
diseas
endeavour
limit
spread
within
flock
humor
cellmedi
immun
respons
play
role
immun
although
rel
contribut
thoroughli
investig
humor
respons
assess
elisa
viru
neutralis
util
commerci
poultri
vaccin
control
poxviru
diseas
avian
speci
question
although
occas
use
attempt
use
without
risk
vaccin
alway
consid
potenti
caus
diseas
vaccin
speci
mani
commerci
vaccin
strain
fwpv
cnpv
use
basi
develop
recombin
poxviru
vectorbas
vaccin
control
avian
diseas
use
nonavian
speci
fwpv
vaccin
associ
inadvert
spread
rev
appar
vaccin
contamin
modern
poultri
vaccin
rare
risk
spread
adventiti
agent
qualiti
assur
process
product
well
establish
nonetheless
associ
fwpv
rev
turn
uniqu
relationship
rev
proviru
integr
fwpv
genom
avail
fullgenom
sequenc
one
fwpv
strain
one
cnpv
open
possibl
ration
attenu
virus
develop
new
avipox
vaccin
enhanc
specif
immunogen
charact
avipoxvirus
use
deliveri
antigen
andor
immunomodul
avian
nonavian
host
recent
remov
integr
rev
proviru
fwpv
vaccin
field
strain
gener
new
vaccin
strain
boyl
unpublish
scale
intens
global
product
commerci
poultri
led
emerg
new
diseas
princip
caus
virus
emerg
variant
exist
virus
come
pressur
develop
new
vaccin
select
new
strain
inclus
vaccin
challeng
come
rna
genom
virus
eg
infecti
bronchiti
viru
infecti
bursal
diseas
viru
ibdv
avian
influenza
viru
howev
marek
diseas
viru
mdv
undergon
substanti
variat
mani
older
vaccin
provid
poor
limit
protect
emerg
mdv
strain
report
emerg
fwpv
strain
caus
unusu
diseas
pattern
diseas
current
vaccin
may
ineffect
potenti
emerg
new
fwpv
strain
spread
avipoxvirus
commerci
poultri
product
system
real
howev
time
consequ
emerg
virus
predict
avipoxvirus
identifi
caus
agent
diseas
wide
rang
avian
speci
review
see
mortal
approach
occas
report
pigeon
quail
canari
highli
pathogen
strain
natur
diseas
wild
cage
bird
rang
mild
cutan
lesion
feet
unfeath
area
sever
diseas
high
mortal
associ
cutan
diphtherit
diseas
poxviru
infect
along
avian
malaria
consid
import
factor
limit
threaten
endang
uniqu
popul
bird
hawaiian
galapago
canari
island
circumst
introduct
poxviru
infect
captiv
breed
program
endang
bird
speci
signific
concern
poxviru
infect
gener
diagnos
clinic
sign
histopatholog
eg
characterist
cytoplasm
inclus
bodi
infect
cell
electron
microscop
detect
viru
lesion
virus
isol
inocul
embryon
egg
avian
cell
cultur
studi
possibl
studi
usual
involv
crossprotect
pathogenesi
studi
chicken
comparison
fwpv
restrict
endonucleas
analysi
genom
dna
sequenc
pcr
amplifi
genom
region
complex
pattern
relationship
fwpv
reveal
avipoxvirus
rare
pathogen
chicken
provid
poor
cross
protect
fwpv
challeng
signific
differ
restrict
endonucleas
profil
genom
sourc
poxviru
infect
wide
rang
avian
speci
specul
upon
viru
infect
could
enzoot
manifest
diseas
stress
environment
factor
viru
diseas
might
spill
relat
speci
domest
poultri
possibl
extend
persist
viru
cutan
warti
lesion
avian
speci
spread
poxviru
one
avian
speci
anoth
habitat
disrupt
insect
transmiss
potenti
caus
sever
diseas
newli
infect
speci
full
natur
complex
relationship
avipoxvirus
reveal
detail
genom
sequenc
analysi
greater
rang
isol
genom
sequenc
analysi
put
gene
function
relationship
avail
pathogen
fwpv
us
fwp
challeng
viru
anim
health
inspect
centr
veterinari
biolog
ame
iowa
plaquepurifi
tissu
cultureadapt
attenu
european
viru
fwpv
cnpv
virul
strain
wheatley
american
type
cultur
collect
addit
genom
wide
differ
fwpv
us
characteris
strain
progenitor
virul
fwpv
fwpv
genom
size
rang
kbp
kbp
pathogen
fwp
challeng
strain
cnpv
genom
kbp
kbp
larger
fwpv
genom
given
size
complex
genom
propos
review
individu
gene
relationship
detail
reader
best
refer
origin
manuscript
level
analysi
case
fwpv
us
resembl
chordopoxvirina
overal
genom
structur
function
centralis
conserv
core
gene
whose
function
involv
basic
replic
mechan
viral
transcript
rna
modif
genom
replic
structur
assembl
matur
virion
conserv
gene
homologu
involv
function
fwpv
us
genom
contain
invert
termin
repeat
approach
kbp
length
gene
express
regulatori
element
eg
earli
intermedi
late
promot
contain
typic
chordopoxvirina
sequenc
earli
poxviru
transcript
termin
sequenc
identifi
near
translat
stop
codon
mani
predict
earli
gene
howev
mark
differ
genom
colinear
comparison
chordopoxvirina
disrupt
fwpv
us
transloc
invers
multipl
larg
gene
famili
novel
cellular
homologu
much
mark
size
differ
fwpv
us
chordopoxvirina
account
larg
number
cellular
homologu
multigen
famili
notabl
fwpv
us
ankyrin
repeat
famili
gene
famili
gene
famili
gene
repres
total
genom
larg
number
put
cellular
homologu
gene
involv
immun
evas
apoptosi
cell
growth
tissu
tropism
cellular
homologu
involv
steroid
biogenesi
antioxid
function
vesicl
traffick
suggest
substanti
modif
host
cell
function
occur
upon
viru
infect
also
suggest
photoreactiv
dna
repair
pathway
encod
fwpv
us
gene
acquisit
horizont
transfer
appear
play
signific
role
adapt
fwpv
us
avian
host
comparison
attenu
tissu
cultureadapt
european
strain
fwpv
us
identifi
differ
gene
affect
delet
bp
insert
bp
substitut
termin
frameshift
fwpv
deriv
virul
european
fwpv
passag
embryon
egg
chicken
embryo
fibroblast
cell
cultur
passag
sequenc
determin
loci
differ
exist
fwpv
us
show
loci
differ
fwpv
us
ident
half
differ
two
geograph
fwpv
lineag
repres
differ
parent
virul
virus
fwpv
us
thu
half
differ
fwpv
us
repres
differ
differ
virus
two
geograph
origin
comparison
attenu
european
virul
parent
fwpv
show
loci
differ
repres
changesmut
accumul
egg
tissu
cultur
passag
attenu
twelv
open
read
frame
affect
appar
passagespecif
mutat
encod
member
ankyrin
repeat
famili
mechan
mutat
lead
attenu
yet
unclear
restrict
endonucleas
enzym
profil
avipoxviru
genom
show
signific
variat
genom
arrang
suggest
potenti
mark
differ
genom
content
limit
gene
sequenc
data
cnpv
tokyo
strain
indic
cnpv
fwpv
appear
share
region
similar
gene
order
mark
differ
deduc
amino
acid
level
gene
homolog
cnpv
fwpv
rang
diverg
compar
seen
differ
chordopoxvirina
genera
substanti
differ
cnpv
fwpv
confirm
full
sequenc
cnpv
genom
cnpv
markedli
larger
fwpv
kbp
versu
kbp
central
region
cnpv
genom
contain
homologu
chordopoxvirina
gene
involv
basic
replic
mechan
viral
transcript
rna
modif
viral
dna
replic
structur
assembl
virion
shown
conserv
chordopoxvirina
gene
share
cnpv
fwpv
averag
amino
acid
ident
cnpv
genom
encod
gene
homologu
absent
fwpv
genom
fragment
cnpv
lack
gene
present
termin
genom
region
fwpv
intern
genom
region
exhibit
consider
variabl
cnpv
fwpv
contrast
rel
overal
conserv
central
region
genom
chordopoxvirina
major
genom
variabl
locat
near
junction
genom
rearrang
rel
chordopoxvirina
region
contain
gene
appear
involv
virushost
interact
cnpv
wheatley
strain
close
relationship
nucleotid
amino
acid
level
cnpv
tokyo
strain
region
compar
sequenc
avail
provid
level
confirm
genom
conserv
differ
isol
caus
cnp
support
design
cnpv
speci
level
avipoxviru
genu
tulman
et
al
conclud
genom
data
phylogen
analysi
individu
open
read
frame
support
monophylet
origin
two
avipoxvirus
rel
chordopoxvirina
diverg
fwpv
cnpv
appear
great
chordopoxvirida
genera
appar
diverg
establish
restrict
endonucleas
analysi
avipoxviru
genom
nucleotid
sequenc
gene
support
conclus
suggest
potenti
substanti
far
rang
genom
divers
amongst
virus
report
caus
diseas
least
speci
order
bird
substanti
sequenc
data
rang
avipoxvirus
understand
avipoxviru
genu
may
constitut
separ
subfamili
within
poxvirida
complet
genom
sequenc
poxvirus
allow
genom
wide
analysi
phylogeni
genom
structur
evolutionari
pathway
gene
order
gene
space
highli
conserv
within
chordopoxvirina
except
fwpv
cnpv
phylogenet
analys
place
fwpv
extern
chordopoxvirina
presum
cnpv
although
similar
analysi
yet
report
notwithstand
conserv
overal
genom
composit
structur
includ
central
core
gene
invert
termin
repeat
larg
number
function
import
ortholog
fwpv
cnpv
genom
exhibit
largescal
genom
rearrang
extens
gene
famili
novel
host
rang
gene
comparison
chordopoxvirina
gene
loss
gain
appear
domin
mechan
evolut
chordopoxvirina
genom
mani
gene
acquir
horizont
gene
transfer
host
fwpv
gain
gene
sinc
diverg
common
ancestor
chordopoxvirina
gene
famili
share
chordopoxvirina
anim
genom
found
fwpv
acquisit
horizont
gene
transfer
import
perhap
domin
sourc
new
gene
avipoxvirus
evolut
mani
acquir
gene
enabl
viru
escap
host
cellular
immunolog
defenc
perhap
import
challeng
poxviru
biolog
understand
rate
mechan
gene
transfer
uniqu
relationship
exist
avian
retroviru
rev
fwpv
near
fulllength
infecti
proviru
rev
found
genom
pathogen
isol
fwpv
least
one
vaccin
strain
fpv
whose
use
discontinu
sourc
rev
poultri
australia
also
carri
infecti
proviru
fwpv
vaccin
strain
known
caus
rev
infect
carri
either
complet
partial
ltr
presenc
full
partial
ltr
fwpv
vaccin
strain
explain
presenc
tandem
repeat
ltr
proviru
structur
inher
unstabl
poxviru
genom
interven
sequenc
rapidli
lost
interor
intramolecular
recombin
instabl
tandem
repeat
sequenc
poxvirus
exploit
construct
recombin
use
transient
domin
select
method
sinc
ltr
integr
proviru
differ
presenc
absenc
full
partial
ltr
upon
loss
rev
proviru
would
depend
upon
crossov
site
recombin
event
ltr
lead
proviru
loss
number
featur
rev
integr
fwpv
genom
suggest
ancient
uniqu
event
proviru
ltr
sequenc
found
singl
locat
fwpv
genom
examin
mainli
encompass
ltr
sequenc
integr
site
sequenc
duplic
normal
occur
proviru
integr
absent
ltr
complet
ltr
delet
rearrang
near
fulllength
proviru
present
proviru
ltr
identifi
fwpv
strain
isol
well
widespread
use
fwpv
vaccin
commerci
poultri
australia
fwpv
field
isol
made
late
earli
carri
rev
proviru
unpublish
observ
fwpv
strain
carri
rev
sequenc
appear
global
distribut
reintegr
recombin
rev
vaccin
strain
carri
ltr
remnant
appear
unlik
scenario
specul
might
lead
pathogen
fwpv
aris
vaccin
strain
field
perhap
explain
appar
vaccin
failur
given
complex
fwpv
genom
undoubt
role
multipl
gene
product
determin
virul
pathogen
reintegr
rev
alon
unlik
suffici
restor
full
virul
fwpv
vaccin
strain
mani
undergon
multipl
passag
cultur
gener
attenu
consequ
gene
loss
rearrang
disrupt
evid
occur
import
rememb
biolog
fwpv
rev
retroviru
integr
take
place
nucleu
infect
cell
welldefin
pathway
fwpv
dna
replic
take
place
cytoplasm
infect
cell
unlik
readili
access
target
rev
integr
given
physic
function
separ
rev
fwpv
infect
cycl
cell
integr
unlik
rare
event
follow
coinfect
cell
fwpv
rev
attempt
gener
reintegr
recombin
vaccin
strain
rev
coinfect
passag
cef
cell
unsuccess
boyl
unpublish
difficult
howev
construct
select
regimen
might
allow
rare
event
detect
contrast
coinfect
cell
cultur
mdv
rev
avian
leukosi
viru
alv
lead
rapid
numer
integr
event
mdv
genom
reflect
mdv
replic
nucleu
infect
cell
readi
target
rev
alv
integr
presenc
rev
proviru
ltr
avipoxvirus
explor
extent
ltr
sequenc
absent
complet
genom
sequenc
cnpv
ortholog
gene
flank
rev
sequenc
fwpv
separ
bp
usa
fwpv
commerci
vaccin
vaccin
plu
parent
strain
recombin
fwpv
pgpv
vaccin
contain
complet
incomplet
rev
ltr
qupv
cnpv
vaccin
contain
integr
rev
sequenc
none
fwpv
vaccin
strain
contain
rev
proviru
contrast
field
isol
fwpv
made
appear
contain
integr
rev
proviru
remain
isol
appear
ltr
remnant
studi
cnpv
pgpv
isol
lack
integr
rev
sequenc
observ
unpublish
avipoxvirus
isol
nativ
avifauna
australia
new
zealand
shown
rev
absent
isol
isol
test
pcr
hybridis
ltr
gag
region
sequenc
show
rev
sequenc
absent
throughout
genom
homolog
site
identifi
fwpv
australian
avipoxviru
isol
poultri
chicken
turkey
gees
pigeon
carri
proviru
ltr
rapid
loss
rev
proviru
upon
passag
field
isol
embryo
cell
cultur
might
expect
due
inher
instabl
proviru
structur
discuss
probabl
occur
exist
commerci
vaccin
strain
passag
select
mainten
rev
proviru
field
strain
fwpv
select
advantag
must
confer
fwpv
strain
carri
rev
proviru
equal
intrigu
mechan
recoveri
rev
infect
chicken
infect
fwpv
strain
carri
rev
proviru
unabl
detect
free
rev
vaccin
strain
fpv
yet
viru
inocul
chicken
gave
rise
rev
infect
chicken
fwpv
isol
undoubtedli
contamin
free
infecti
rev
perhap
reflect
coisol
fwpv
rev
chicken
embryo
cell
cultur
use
isol
integr
near
fulllength
rev
proviru
infecti
sinc
transfect
ecoridigest
fwpv
dna
cef
cell
result
recoveri
infecti
rev
express
rev
genom
proviru
ltr
promot
unlik
sinc
promot
would
recognis
poxviru
transcript
machineri
express
rev
protein
report
howev
coisol
rev
fwpv
cultur
system
could
explan
appar
express
rev
gene
fwpv
carri
integr
rev
proviru
select
advantag
confer
fwpv
strain
carri
rev
proviru
probabl
relat
immunosuppress
caus
concurr
rev
infect
lead
longer
sever
fwp
infect
thu
extend
durat
possibl
transmiss
contact
mosquito
although
suggest
widespread
fwpv
vaccin
might
provid
select
pressur
retent
rev
proviru
fwpv
seem
unlik
sinc
rev
proviru
detect
isol
made
widespread
use
fwvp
vaccin
poultri
upon
remov
rev
proviru
two
field
strain
fpv
vaccin
strain
fwpv
abl
identifi
mark
differ
diseas
produc
chicken
infect
week
age
boyl
unpublish
remov
rev
ltr
consid
desir
use
fwpv
strain
poultri
vaccin
vaccin
vector
process
construct
complex
vaccin
vector
remov
remnant
ltr
use
locu
insert
hiv
vaccin
antigen
observ
appar
impact
upon
viru
replic
vitro
relationship
fwpv
rev
lead
mechan
retroviru
transmit
infect
cycl
poxviru
includ
mechan
transmiss
bite
insect
earlier
observ
rev
transmiss
bite
insect
might
better
explain
transmiss
via
fwpv
fwpv
perhap
observ
one
exampl
poxviru
gain
genet
inform
advantag
anoth
viru
equal
rev
gain
signific
advantag
transmit
mosquito
upon
develop
techniqu
construct
recombin
vaccinia
virus
deliv
heterolog
antigen
vaccin
great
deal
interest
gener
potenti
use
speciesspecif
poxvirus
eg
fwpv
cnpv
similar
manner
time
pauciti
knowledg
regard
molecular
biolog
avipoxvirus
consequ
obviou
techniqu
develop
vaccinia
viru
recombin
would
directli
applic
construct
avipox
recombin
first
attempt
construct
rfwpv
rcnpv
direct
use
vector
deliveri
poultri
vaccin
novel
find
rfwpv
rcnpv
could
enter
nonavian
cell
type
undergo
abort
nonproduct
replic
cycl
express
foreign
encod
vaccin
antigen
thu
induc
immun
respons
mammal
led
expand
interest
avipoxvirus
vaccin
vector
gener
accept
avipoxvirus
caus
product
infect
thu
diseas
avian
speci
earli
studi
indic
upon
intranas
inocul
mice
absenc
replic
limit
patholog
cell
cultur
cytopatholog
occur
without
replic
avipoxvirus
examin
appear
gener
abil
enter
nonavian
cell
howev
stage
replic
block
appear
differ
depend
upon
cell
type
recent
unconfirm
report
fwpv
product
infect
babi
hamster
kidney
cell
line
consequ
abort
replic
cycl
avipoxviru
recombin
vaccin
vector
offer
signific
safeti
advantag
use
deliv
vaccin
antigen
mammalian
speci
comparison
replic
compet
poxviru
vector
eg
vaccinia
viru
larg
number
rfwpv
rcnpv
describ
design
express
vaccin
antigen
deliveri
mammalian
host
mani
progress
veterinari
human
clinic
trial
includ
vaccin
candid
hivaid
malaria
tab
safeti
profil
recombin
well
establish
signific
number
recombin
subject
regulatori
substanti
understand
molecular
biolog
orthopoxvirus
essenti
construct
first
vaccinia
viru
recombin
subsequ
shown
avipoxvirus
share
mani
basic
featur
orthopoxvirus
particularli
control
gene
express
eg
promot
transcript
termin
sequenc
essenti
featur
requir
construct
avipoxviru
recombin
summaris
poxviru
promot
gene
express
site
insert
foreign
gene
either
within
nonessenti
gene
gene
suitabl
method
identif
select
recombin
addit
prudent
consid
remov
earli
poxviru
transcript
termin
sequenc
gene
express
presenc
may
abort
significantli
attenu
earli
gene
express
cell
impact
upon
induct
cellmedi
respons
may
also
occur
demonstr
vaccinia
viru
late
gene
express
may
induc
cellmedi
immun
respons
impact
formal
shown
avipoxviru
recombin
knowledg
might
argu
late
gene
express
fwpv
less
like
affect
cellmedi
immun
respons
sinc
fwpv
shut
host
cell
protein
synthesi
extent
vaccinia
viru
antigen
process
mhc
class
antigenpres
pathway
shown
mechan
vaccinia
viru
inhibit
cellmedi
immun
respons
induct
late
express
gene
product
avipoxviru
recombin
intend
anim
human
clinic
trial
essenti
use
cell
substrat
accept
purpos
consequ
growth
plaqu
must
undertaken
chicken
embryo
cell
cultur
deriv
certifi
sourc
specif
pathogenfre
embryon
egg
addit
full
document
traceabl
biolog
materi
use
construct
growth
recombin
requir
regulatori
approv
test
recombin
human
work
essenti
need
conduct
glp
good
laboratori
practic
protocol
cell
substrat
eg
transform
quail
cell
line
accept
vaccin
contempl
clinic
use
although
suitabl
construct
recombin
research
purpos
construct
recombin
avipoxvirus
embark
upon
lightli
sinc
time
requir
construct
recombin
mani
month
contrast
vaccinia
viru
recombin
construct
week
time
differ
reflect
much
longer
replic
cycl
avipoxvirus
comparison
vaccinia
viru
gener
demonstr
promot
sequenc
one
poxviru
oper
across
genera
chordopoxvirina
retain
tempor
regul
promot
vaccinia
viru
p
earli
late
promot
wide
use
construct
recombin
poxvirus
includ
rfwpv
rcnpv
choic
promot
appear
larg
driven
conveni
access
endogen
fwpv
cnpv
promot
frequent
use
along
vaccinia
viru
optimis
synthet
earli
earlyl
promot
ration
choic
promot
optim
gene
express
recombin
avipoxvirus
entir
clear
studi
attempt
compar
promot
level
express
promot
optimis
sequenc
modif
undertaken
vaccinia
viru
pauciti
evid
support
belief
higher
gene
express
level
necessarili
lead
better
immun
respons
certain
antigen
natur
antigen
rather
express
level
achiev
recombin
avipoxvirus
greater
impact
immunogen
key
featur
insert
site
disrupt
gene
function
might
affect
vivo
vitro
replic
gene
express
stabl
recombin
plaqu
purifi
larg
genom
size
avipoxvirus
suggest
mani
potenti
insert
site
far
describ
date
larg
capac
carri
multipl
gene
insert
either
individu
multipl
site
thymidin
kinas
gene
fwpv
use
locu
construct
recombin
howev
circumst
stabl
recombin
proven
difficult
obtain
abl
obtain
stabl
recombin
within
thymidin
kinas
gene
howev
may
reflect
fwpv
strain
fpv
cell
type
use
chicken
embryo
skin
cell
other
shown
inactiv
thymidin
kinas
gene
affect
effici
replic
rfwpv
use
thymidin
kinas
site
insert
perhap
best
avoid
mani
potenti
site
includ
immedi
downstream
thymidin
kinas
gene
encount
difficulti
gener
stabl
recombin
occas
approxim
recombin
construct
instabl
appear
relat
gene
insert
although
unstabl
recombin
common
factor
difficult
identifi
follow
recombin
event
gener
infect
cell
cultur
parent
viru
transfect
suitabl
construct
plasmid
recombin
identifi
gene
hybridis
express
howev
proport
recombin
low
less
viru
yield
make
plaqu
purif
recombin
challeng
coexpress
escherichia
coli
xanthin
guanin
ribosyl
transferas
gene
confer
resist
mycophenol
acid
conveni
select
marker
amplif
recombin
addit
coexpress
lac
z
gene
allow
conveni
identif
plaqu
purif
recombin
basi
blue
stain
plaqu
suitabl
galactosidas
enzym
substrat
domin
select
select
marker
gene
retain
final
recombin
presenc
recombin
intend
human
clinic
trial
may
problemat
stage
regulatori
approv
although
rfwpv
carri
gene
approv
jurisdict
human
clinic
trial
use
transient
domin
select
insert
vaccin
therapeut
gene
avipoxviru
recombin
consid
select
marker
gene
retain
final
recombin
select
marker
gene
reus
make
addit
insert
differ
loci
allow
construct
complex
recombin
carri
multipl
antigen
gene
immun
modul
multipl
round
least
three
four
plaqu
purif
gener
requir
gener
homogen
stabl
recombin
thereaft
hand
recombin
stabl
multipl
gener
requir
master
work
seed
lot
final
trial
vaccin
batch
prepar
human
clinic
trial
avail
plasmid
vector
gener
select
amplif
techniqu
domin
transient
domin
select
facilit
construct
complex
rfwpv
use
vaccin
trial
descript
bacteri
artifici
chromosom
vector
construct
vaccinia
viru
recombin
depend
upon
use
fwpv
recov
infecti
vaccinia
viru
poxviru
dna
poxviru
dna
noninfecti
howev
nongenet
reactiv
wherebi
infecti
viru
recov
inactiv
poxviru
coinfect
unrel
poxviru
infecti
inactiv
differ
manner
provid
mechan
recoveri
infecti
viru
nake
poxviru
dna
sinc
product
avipoxviru
infect
restrict
avian
cell
fwpv
nongenet
reactiv
poxvirus
avian
nonavian
cell
provid
facil
mechan
recoveri
infecti
poxviru
nake
dna
contamin
fwpv
simpli
remov
passag
nonavian
cell
recoveri
fwpv
dna
demonstr
date
howev
possibl
use
poxviru
whose
replic
nonpermiss
avian
cell
whose
infect
suitabl
inactiv
conserv
poxviru
promot
transcript
element
across
poxviru
genera
suggest
readi
explan
mechan
occas
fwpv
incorrectli
describ
provid
packag
helper
viru
function
use
rna
polymeras
transient
gene
express
negativestrand
rna
viru
rescu
pioneer
use
vaccinia
viru
express
polymeras
replac
vaccinia
viru
wild
type
modifi
vaccinia
ankara
fwpv
express
advantag
reduc
cytopath
effect
nonavian
cell
compar
level
express
handl
safeti
lack
product
infect
recoveri
rescu
viru
simplifi
sinc
remov
achiev
passag
nonavian
cell
cultur
vaccin
poultri
rfwpv
express
avian
influenza
haemagglutinin
ha
induc
protect
experiment
natur
infect
highli
pathogen
avian
influenza
hpai
clinic
diseas
mortal
reduc
prevent
even
though
haemagglutin
inhibit
hi
antibodi
titr
follow
vaccin
low
undetect
rfwpvexpress
influenza
nucleoprotein
np
fail
provid
protect
protect
antibodi
mediat
hatyp
specif
interestingli
recent
report
show
provid
protect
hpai
challeng
presum
crossprotect
mediat
via
immun
common
neuraminidas
shed
avian
influenza
viru
via
respiratori
enter
rout
significantli
reduc
vaccin
bird
thu
reduc
potenti
spread
antibodi
respons
ha
np
rise
rapidli
follow
challeng
suggest
substanti
level
replic
challeng
viru
even
though
diseas
occur
restrict
antibodi
respons
ha
follow
vaccin
induct
high
titr
antibodi
ha
np
follow
infect
use
discrimin
vaccin
bird
flock
avian
influenza
hpai
lpai
may
circul
sinc
latter
flock
antibodi
ha
np
socal
diva
test
differenti
infect
vaccin
anim
optimis
ha
insert
may
necessari
provid
effect
field
protect
avian
influenza
singl
recombin
provid
adequ
protect
influenza
viru
isol
four
contin
period
prior
vaccin
field
exposur
fwpv
may
limit
use
rfwpvinfluenza
vaccin
protect
afford
avian
influenza
challeng
inconsist
circumst
alon
combin
avian
influenza
vaccin
wide
use
mexico
approach
billion
dose
vaccin
use
hpai
asia
profound
impact
poultri
product
current
consid
greatest
threat
emerg
pandem
human
influenza
rfwpvinfluenza
vaccin
potenti
find
widespread
applic
poultri
vaccin
asia
use
date
document
chicken
turkey
vaccin
efficaci
duck
water
bird
need
demonstr
rfwpv
rpgpv
express
haemagglutininneuraminidas
hn
fusion
f
protein
newcastl
diseas
viru
ndv
provid
protect
challeng
virul
ndv
efficaci
may
enhanc
express
hn
f
use
rfwpv
conjunct
convent
ndv
vaccin
primeboost
vaccin
regimen
ndv
hi
antibodi
respons
markedli
elev
chicken
vaccin
live
inactiv
ndv
vaccin
prior
vaccin
rfwpvhn
geometr
mean
ndv
hi
titr
higher
contrast
chicken
previous
vaccin
nonrecombin
fwpv
vaccin
fail
develop
ndv
hi
antibodi
follow
vaccin
rfwpvhn
protect
challeng
virul
ndv
candid
rfwpv
vaccin
number
poultri
pathogen
evalu
tab
vaccin
success
achiev
predominantli
glycoprotein
envelop
virus
eg
avian
leukosi
avian
influenza
mdv
ndv
rev
turkey
rhinotrach
viru
except
infecti
bursal
diseas
viru
ibdv
haemorrhag
enter
turkey
rfwpv
express
protein
hexon
respect
shown
induc
protect
immun
rfwpv
vaccin
candid
coccidiosi
infecti
bronchiti
viru
boyl
unpublish
observ
variabl
limit
success
host
genet
shown
play
role
efficaci
rfwpv
candid
vaccin
chicken
ibdv
mdv
sinc
studi
conduct
use
inbr
chicken
clear
genet
effect
play
role
limit
efficaci
commerci
product
breed
also
clear
observ
differ
relat
inher
featur
antigen
deliveri
rfwpv
heterolog
primeboost
vaccin
regimen
coexpress
immunestimulatorsmodul
found
favour
mechan
improv
immunogen
rfwpvbase
vaccin
ndv
hi
antibodi
respons
markedli
elev
chicken
vaccin
live
inactiv
ndv
vaccin
prior
vaccin
rfwpvhn
geometr
mean
ndv
hi
titr
higher
sequenti
vaccin
recombin
mdv
rfwpv
express
gene
ibdv
markedli
improv
protect
gross
lesion
upon
challeng
virul
ibdv
chicken
coexpress
gene
ibdv
report
significantli
improv
protect
afford
ibdv
coexpress
rfwpv
chicken
type
interferon
ndv
hn
f
gene
reduc
postvaccin
bodi
weight
loss
vaccin
use
ovo
shortli
hatch
howev
antibodi
respons
ndv
reduc
coexpress
interferon
ovo
vaccin
turkey
rfwpv
express
hn
f
ndv
chicken
type
ii
interferon
demonstr
earlier
induct
antibodi
ndv
without
advers
effect
hatchabl
treatment
chicken
rfwpv
express
chicken
myelomonocyt
growth
factor
cmgf
prolong
surviv
time
reduc
viraemia
tumour
incid
highli
suscept
chicken
challeng
virul
mdv
addit
rfwpv
cmgf
treatment
improv
vaccin
protect
provid
herp
viru
turkey
vaccin
innat
acquir
immun
respons
appear
enhanc
follow
rfwpv
cmgf
treatment
safeti
profil
offer
rfwpv
rcnpv
deliv
vaccin
nonavian
speci
make
attract
vaccin
vector
wide
rang
anim
speci
tab
experiment
studi
success
induct
protect
immun
respons
predominantli
occur
glycoprotein
antigen
envelop
virus
rfwpv
andor
rcnpv
express
antigen
rabi
canin
distemp
felin
leukaemia
west
nile
virus
provid
effect
protect
diseas
express
rabi
glycoprotein
rfwpv
provid
protect
diseas
mice
cat
dog
compar
studi
vaccinia
viru
rfwpv
rcnpv
express
rabi
glycoprotein
rcnpv
elicit
better
neutralis
antibodi
approxim
time
effect
induc
protect
immun
respons
rfwpv
protect
provid
immunis
rcnpv
significantli
differ
induc
replic
compet
vaccinia
viru
rabi
glycoprotein
recombin
although
level
rabi
glycoprotein
express
slightli
higher
rcnpv
rfwpv
differ
suffici
account
mark
differ
protect
induc
greater
efficaci
rcnpv
probabl
motiv
extens
develop
cnpv
alvac
vaccin
vector
prefer
fwpv
clear
differ
immunogen
would
necessarili
hold
antigen
express
rcnpv
rfwpv
canin
distemp
import
diseas
provid
use
model
vaccin
studi
morbillivirus
eg
rinderpest
measl
rcnpv
alvac
express
ha
f
canin
distemp
viru
provid
high
level
protect
symptomat
diseas
ferret
challeng
model
dog
rcnpv
vaccin
safe
could
use
combin
canin
vaccin
without
detriment
effect
perform
vaccin
oral
vaccin
deliveri
found
effect
vaccin
rout
induc
protect
immun
highli
suscept
siberian
pole
cat
model
potenti
vaccin
use
endang
blackfoot
ferret
intranas
vaccin
rcnpv
alvac
recombin
vaccinia
viru
express
ha
f
young
ferret
induc
lower
level
neutralis
antibodi
provid
poorer
protect
anim
vaccin
parenter
rfwpv
vaccinia
viru
vaccin
express
rinderpest
hn
f
gene
provid
modest
level
protect
canin
distemp
ferret
demonstr
abil
gener
crossreact
immun
morbillivirus
spread
west
nile
viru
north
america
led
substanti
veterinari
public
health
issu
effect
vaccin
control
west
nile
diseas
hors
base
upon
rcnpv
express
prme
protein
licens
use
hors
singl
intramuscular
dose
vaccin
provid
protect
develop
viraemia
eight
nine
hors
follow
challeng
day
post
vaccin
use
west
nile
virusinfect
mosquito
even
absenc
measur
antibodi
respons
hors
two
dose
vaccin
provid
effect
protect
develop
mosquitotransmit
viraemia
least
year
post
vaccin
mark
amnest
antibodi
respons
observ
hors
previous
vaccin
inactiv
west
nile
viru
vaccin
subsequ
boost
rcnpv
vaccin
primeboost
vaccin
regimen
rcnpv
express
env
gag
gene
felin
leukaemia
viru
provid
high
level
protect
oronas
challeng
felin
leukaemia
viru
protect
last
least
year
effect
sever
contact
challeng
obtain
absenc
detect
antibodi
env
antigen
high
proport
cat
fail
develop
latent
infect
follow
challeng
use
combin
felin
vaccin
impact
upon
perform
rcnpv
vaccin
vaccin
search
effect
hivaid
vaccin
perhap
greatest
biomed
research
challeng
exist
today
area
rfwpv
rcnpv
explor
great
detail
propos
review
area
extens
well
cover
specialis
review
underli
interest
safeti
profil
avipoxvirus
nonavian
host
observ
heterolog
primeboost
vaccin
regimen
enhanc
direct
immun
respons
dna
vaccin
poorli
immunogen
vaccin
coexpress
immunostimulatorymodulatori
molecul
enhanc
modifi
natur
respons
much
emphasi
rfwpv
rcnpv
use
primeboost
vaccin
regimen
gener
enhanc
cellmedi
immun
respons
studi
nonhuman
primat
shown
approach
induc
elev
level
cellular
immun
provid
effect
level
immun
hiv
shiv
reduc
peak
set
viral
load
albeit
without
prevent
infect
regrett
date
earli
phase
human
clinic
trial
dna
rfwpv
primeboost
vaccin
regimen
provid
disappoint
result
coexpress
immunostimulatorymodulatori
molecul
conjunct
hiv
antigen
attract
scientif
hand
face
substanti
regulatori
hurdl
propos
use
nonhiv
infect
individu
rfwpv
express
hiv
antigen
human
interferonha
test
phase
iiia
therapeut
vaccin
trial
hivposit
individu
howev
result
disappoint
contrast
hivaid
primeboost
vaccin
regimen
involv
dna
vaccin
rfwpv
provid
promis
level
cellmedi
immun
malaria
includ
plasmodium
falciparum
preclin
human
clinic
trial
rfwpv
rcnpv
explor
deliveri
vaccin
cytomegaloviru
hepat
b
c
virus
japanes
enceph
viru
measl
viru
rabi
viru
mycobacterium
tab
cancer
therapi
area
rfwpv
rcnpv
explor
see
whether
express
cancer
antigen
immunostimulatori
modulatori
molecul
develop
novel
treatment
regimen
larg
grow
area
research
well
cover
specialis
literatur
area
immunostimulatorymodulatori
molecul
explor
sinc
safeti
concern
overridden
extent
absenc
treatment
regimen
higher
level
risk
accept
includ
direct
intratumour
inject
rfwpv
rcnpv
express
tumour
antigen
immunostimul
attempt
break
self
toler
avipoxvirus
gone
neglect
obscur
import
vaccin
vector
past
year
semin
observ
util
deliveri
vaccin
antigen
nonavian
speci
driven
much
interest
group
virus
extent
rfwpv
rcnpv
undergon
extens
clinic
trial
human
vaccin
hivaid
treatment
regimen
cancer
patient
applic
vaccin
vector
avian
nonavian
speci
success
glycoprotein
antigen
envelop
virus
express
interest
human
area
driven
safeti
profil
gener
enhanc
direct
respons
primeboost
vaccin
regimen
abil
coexpress
immunostimulatorymodulatori
molecul
explor
basic
molecular
virolog
avipoxvirus
thrown
light
evolutionari
pathway
poxvirida
futur
may
necessari
consid
avipoxviru
genu
separ
subfamili
within
poxvirida
outsid
chordopoxvirina
intrigu
uniqu
relationship
exist
fwpv
rev
one
fascin
stori
emerg
studi
group
virus
provid
consist
accuraci
manuscript
adopt
nomenclatur
abbrevi
use
ictv
report
howev
refer
specif
isol
strain
viru
nomenclatur
abbrevi
adopt
public
isol
strain
describ
use
eg
taylor
